At the 2016 RSNA Scientific Assemble and Annual Meeting, two additional healthcare industry imaging and hardware companies have turned to Materialise to help develop 3D printed anatomical models for their customers.Siemens Healthineers, a global leader in medical imaging, laboratory diagnostics, and healthcare information technology, will use Materialise Mimics technology to help healthcare providers bring 3D printing operations in house. Through this partnership, clinicians will be able to 3D print complex anatomical models directly from their Siemens environment. This program is on display in Siemens Healthineers' exhibit, located at RSNA, located at booth #1936. Carestream, a worldwide provider of dental and medical imaging systems and healthcare IT solutions, will leverage Materialise's AnatomyPrint 3D printing service to improve access to anatomical models for radiologists and other healthcare professionals. This program is on display in Carestream's exhibit at RSNA, located at booth #4704 in South Hall A. Materialise software and services are also on display in its exhibit at RSNA, located at booth #7808 in North Hall B. About MaterialiseMaterialise incorporates more than 25 years of 3D printing experience into a range of software solutions and 3D printing services, which together form the backbone of 3D printing technologies. Materialise's open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines the largest group of software developers in the industry with one of the largest 3D printing facilities in the world. For additional information, please visit: www.materialise.com. Cautionary Statement on Forward-Looking StatementsSome of the statements in this press release are "forward-looking" and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements relating to, among other things, our planned commercialization efforts and regulatory approvals of our technologies as well as the success thereof and our research and development projects. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control that may cause our actual results to differ materially from our expectations. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this presentation as a result of new information, future events or otherwise, unless we have obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.